MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Can we customize tune for asymmetric tremor with differentiated Deep brain stimulation frequencies?

    G. Baille, A. Kreisler, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: We aimed to display if differentiated frequency can improve the tremor in patients with STN-DBS. Background: Subthalamic deep brain stimulation (STN-DBS) is the best…
  • MDS Virtual Congress 2020

    Opicapone’s added benefit as a first-line adjunctive therapy to levodopa and when used promptly in the motor fluctuations spectrum of Parkinson’s disease: a post-hoc analysis of BIPARK-I and II

    G. Ebersbach, J. Ferreira, A. Antonini, A.T Santos, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Beelitz, Germany)

    Objective: To evaluate opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuations according to disease- and therapy-related characteristics. Background: OPC, a once-daily catechol-O-methyltransferase inhibitor,…
  • MDS Virtual Congress 2020

    Comparing the effects of rosemary and selegiline on behavioral symptoms of Parkinson’s animal model in mice

    M. Modaresi (Isfahan, Islamic Republic of Iran)

    Objective: Parkinson is from common disorders of central nervous system and the second disease in neurodegenerative diseases which occurs in 1% of people over the…
  • MDS Virtual Congress 2020

    High Satisfaction and Improved Quality of Life with Rock Steady Boxing in Parkinson’s Disease

    D. Larson, D. Bega, M. Rafferty, C. Yeh (Chicago, IL, USA)

    Objective: To compare demographics, self-reported symptom burden, Health-Related Quality of Life (HRQL), and Exercise Self-Efficacy (ESE) between Rock Steady Boxing (RSB) participants and non-participants. Background:…
  • MDS Virtual Congress 2020

    Pharmacokinetics of Levodopa in patients with Parkinson’s disease: Efforts toward a predictive model

    N. Nishikawa, H. Iwaki, T. Shiraishi, Y. Mukai, Y. Takahashi, N. Hattori (Kodaira, Japan)

    Objective: Our aim was to explore correlations between the pharmacokinetics of levodopa (LD) and clinical manifestation in patients with Parkinson’s disease (PD). Our goal was…
  • MDS Virtual Congress 2020

    Indication and long-term outcome of device-aided therapies in advanced Parkinson’s disease

    M. Shiraishi, F. Maki, M. Kato, Y. Morosawa, I. Takumi, K. Isahaya, N. Sasaki, Y. Hasegawa (Kawasaki, Japan)

    Objective: We aimed to demonstrate the real world differences in a single center. Background: Number of deep brain stimulation (DBS) and levodopa-carbidopa continuous infusion gel…
  • MDS Virtual Congress 2020

    Identification and characterization of anti-prionic compounds that disassemble αSyn prions as a novel therapeutic approach for synucleinopathies

    D. Willbold, M. Sevenich, W. Hoyer, J. Mohrlüder, A. Willuweit (Jülich, Germany)

    Objective: Stabilization of monomeric α-synuclein protein (αSyn) by transient and high-affinity binding ligands is a novel and highly innovative anti-prionic treatment strategy for synucleinopathies .…
  • MDS Virtual Congress 2020

    Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy

    Y. Saitoh, M. Miyazaki, A. Tsuru, Y. Takahashi (Kodaira, Tokyo, Japan)

    Objective: To investigate whether REM sleep without atonia (RWA) is associated with sleep architecture in patients with multiple system atrophy (MSA). Background: In MSA patients,…
  • MDS Virtual Congress 2020

    Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial

    M. Dale, B. Brumbach, A. Hiller (Portland, OR, USA)

    Objective: Amantadine anecdotally improves gait and balance in PSP, potentially by increasing alertness, but there are no definitive data to support this observation. We investigated…
  • MDS Virtual Congress 2020

    Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism

    D.T Akramova (Tashkent, Uzbekistan)

    Objective: It is known that, in vascular parkinsonism (VP) and Parkinson’s disease (PD) it is observed shortening of steps, bradikinesia, oligokinesia, gait disorders and also…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley